Biosensors Market

The global biosensors market is projected to grow from USD 34.51 billion in 2025 to USD 54.37 billion by 2030, at a CAGR of 9.5% from 2025 to 2030. One of the key factors boosting the demand for biosensors is the emergence of nanotechnology-based biosensors and the increasing use of biosensors to monitor glucose levels in individuals with diabetes. The rising geriatric population, deteriorating lifestyle, and growing viral infections also augment the demand for portable healthcare devices. In recent years, wearable healthcare products have become popular due to the increasing demand for wearable devices. These sensors are incorporated into wearable healthcare devices to monitor the patient’s health continuously. The increasing popularity of portable and wearable healthcare devices is a major factor driving the market.

Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), and ACON Laboratories (US) are the major players in the market. Market participants have increased their product offerings, expanding their global reach through strategic growth approaches, including product launches, collaborations, and partnerships. For instance, in August 2024, Abbott Laboratories announced a partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's FreeStyle Libre technology that will connect with Medtronic's automated insulin delivery (AID) and smart insulin pen systems.

To know about the assumptions considered for the study download the pdf brochure

Major Biosensors Companies Include:

• Abbott Laboratories (US)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Medtronic (Ireland)
• Bio-Rad Laboratories, Inc. (US)
• DuPont (US)
• Biosensors International Group, Ltd. (Singapore)
• Dexcom, Inc. (US)
• Masimo (US)
• Nova Biomedical (US)
• Universal Biosensors (Australia)
• ACON Laboratories (US)

Abbott Laboratories (US):

Abbott Laboratories is a global healthcare leader that helps people at all stages of life. The company’s portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional, and branded generic medicines. The company has four business segments, namely, Medical Devices, Diagnostic Products, Nutritional Products, and Pharmaceutical Products. The company’s revolutionary sensing technology, FreeStyle Libre System, is a life-changing innovation that offers a convenient way to get more frequent glucose readings. Libre is a small sensor worn on the arm that continuously measures the amount of glucose in the blood. The company also offers FreeStyle Libre Pro System, a professional continuous glucose-monitoring device that lets doctors detect trends and track glucose-level patterns, helping them make therapy adjustments for their patients.

F. Hoffmann-La Roche Ltd (Switzerland):

F. Hoffmann-La Roche Ltd is one of the world’s largest biotech companies with differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. Roche is also the world leader in IVD and tissue-based cancer diagnostics and a frontrunner in diabetes management. 30 medicines developed by Roche are in the WHO Model Lists of Essential Medicines, including life-saving antibiotics, antimalarials, and cancer medicines. F. Hoffmann-La Roche Ltd has been recognized as the Group Leader in sustainability within the pharmaceuticals, biotechnology & life sciences industry. The company has two reportable segments: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division comprises the two business subsegments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of the following four business areas: Centralized and Point of Care Solutions, Molecular Diagnostics, Tissue Diagnostics, and Diabetes Care.

Market Ranking

The market is consolidated, with leading players, such as Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), and DuPont (US), collectively accounting for approximately 35–45% of the market share. The biosensors market has evolved over the last decade. Major players are adopting organic and inorganic growth strategies, including product launches, acquisitions, and contracts & agreements. These strategies have not only helped the market leaders gain extra revenue but have also helped them sustain their position in the changing market dynamics and cater to the various needs of customers.

Related Reports:

Biosensors Market by Type (Sensor Patch, Embedded Device), Product (Wearable, Non-Wearable), Wearable (Wristwear, Bodywear), Technology (Electrochemical, Optical, Piezoelectric, Thermal, Nanomechanical), Application and Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com